These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24740764)

  • 41. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
    Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
    Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence, survival outcomes, and clinicopathologic factors associated with negative high risk human papillomavirus in surgical specimens of cervical cancer with pretreatment negative DNA genotype test.
    Chong GO; Han HS; Park JY; Lee SD; Lee YH; Lee HJ; Hong DG; Lee YS
    Int J Gynecol Cancer; 2019 Jan; 29(1):10-16. PubMed ID: 30640677
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high-risk HPV-positive women.
    Chen X; Wei S; Ma H; Jin G; Hu Z; Suping H; Li D; Hang D; Wu X; Li N
    Cancer Med; 2019 Aug; 8(10):4845-4851. PubMed ID: 31243901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of MCM2 detection with stage and virology of cervical cancer.
    Amaro Filho SM; Nuovo GJ; Cunha CB; Ramos Pereira Lde O; Oliveira-Silva M; Russomano F; Pires A; Nicol AF
    Int J Biol Markers; 2014 Dec; 29(4):e363-71. PubMed ID: 24706378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HPV-negative tumors of the uterine cervix.
    Nicolás I; Marimon L; Barnadas E; Saco A; Rodríguez-Carunchio L; Fusté P; Martí C; Rodriguez-Trujillo A; Torne A; Del Pino M; Ordi J
    Mod Pathol; 2019 Jul; 32(8):1189-1196. PubMed ID: 30911077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HPV distribution in cervical cancer in Portugal. A retrospective study from 1928 to 2005.
    Félix A; Alemany L; Tous S; de Sanjosé S; Bosch FX
    Papillomavirus Res; 2016 Dec; 2():41-45. PubMed ID: 29074184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. About invasive cervical cancer: a French population based study between 1998 and 2010.
    Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased High-Risk Human Papillomavirus Viral Load Is Associated With Immunosuppressed Microenvironment and Predicts a Worse Long-Term Survival in Cervical Cancer Patients.
    Cao M; Wang Y; Wang D; Duan Y; Hong W; Zhang N; Shah W; Wang Y; Chen H
    Am J Clin Pathol; 2020 Mar; 153(4):502-512. PubMed ID: 31819948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of human papillomavirus viral load in correlation with different therapeutic modalities in cervical cancer patients.
    Cao M; Shah W; Qi J; Zhou Y; Wang Y; Chen H
    Pathol Res Pract; 2016 Sep; 212(9):804-10. PubMed ID: 27461827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA.
    Higgins GD; Davy M; Roder D; Uzelin DM; Phillips GE; Burrell CJ
    Lancet; 1991 Oct; 338(8772):910-3. PubMed ID: 1681267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mortality of non-participants in cervical screening: Register-based cohort study.
    Dugué PA; Lynge E; Rebolj M
    Int J Cancer; 2014 Jun; 134(11):2674-82. PubMed ID: 24288241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types.
    Lai HC; Sun CA; Yu MH; Chen HJ; Liu HS; Chu TY
    Int J Cancer; 1999 Dec; 84(6):553-7. PubMed ID: 10567897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy.
    Harima Y; Sawada S; Nagata K; Sougawa M; Ohnishi T
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1345-51. PubMed ID: 11955748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of human papillomavirus cell-free DNA in cervical cancer patients: A systematic review and meta-analysis.
    Wang ZY; Li R; Li RZ; Pei KG; Sun LF; Wang HJ
    Eur J Obstet Gynecol Reprod Biol; 2024 Sep; 300():211-218. PubMed ID: 39029243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microsatellite instability and HPV genotype in Polish women with cervical cancer.
    Baay MF; Nakonieczny M; Wozniak I; Deschoolmeester V; Liss J; Lukaszuk K; Sotlar K; Emerich J; Vermorken JB
    Eur J Gynaecol Oncol; 2009; 30(2):162-6. PubMed ID: 19480245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer.
    Mendoza RP; Haidary T; Gabutan E; Zhou YY; Bukhari Z; Connelly C; Lee WC; Lee YC; Wadgaonkar R; Agrawal R; Haseeb MA; Gupta R
    Sci Rep; 2021 Jul; 11(1):14064. PubMed ID: 34234252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Presence of Human Papillomavirus DNA Integration is Associated with Poor Clinical Results in Patients with Third-Stage Cervical Cancer.
    Kiseleva VI; Mkrtchyan LS; Ivanov SA; Lyubina LV; Bezyaeva GP; Panarina LV; Krikunova LI; Zamulaeva IA
    Bull Exp Biol Med; 2019 Nov; 168(1):87-91. PubMed ID: 31768781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer.
    Unger ER; Vernon SD; Thoms WW; Nisenbaum R; Spann CO; Horowitz IR; Icenogle JP; Reeves WC
    J Infect Dis; 1995 Nov; 172(5):1184-90. PubMed ID: 7594652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer.
    Sivars L; Jylhä C; Crona Guterstam Y; Zupancic M; Lindqvist B; Nordenskjöld M; Tham E; Hellman K
    Clin Cancer Res; 2024 Jul; 30(13):2764-2771. PubMed ID: 38669077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.